Search

  • HOME
  • Search
1747
Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Yi-wen Shi, Jian-Gao Fan
Clin Mol Hepatol. 2023;29(Suppl):S228-S243.   Published online December 14, 2022
View: 3257   Download: 103
1738
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2023;29(Suppl):S184-S195.   Published online December 5, 2022
View: 3476   Download: 171  Web of Science: 8  Crossref: 8
Original Article
1790
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
Clin Mol Hepatol. 2023;29(3):693-704.   Published online March 9, 2023
View: 2772   Download: 157  Web of Science: 3  Crossref: 3
Editorial
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
Clin Mol Hepatol. 2023;29(2):404-407.   Published online March 14, 2023
View: 2444   Download: 69  Web of Science: 2  Crossref: 2
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Ho Soo Chun, Minjong Lee
Clin Mol Hepatol. 2023;29(2):377-380.   Published online March 9, 2023
View: 2226   Download: 92  Web of Science: 2  Crossref: 1
Snapshot
1689
Personalized medicine in nonalcoholic fatty liver disease
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):935-938.   Published online June 24, 2022
View: 3467   Download: 135  Web of Science: 4  Crossref: 4
Editorial
1701
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):806-809.   Published online August 19, 2022
View: 2263   Download: 61
Review
1678
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clin Mol Hepatol. 2022;28(4):790-801.   Published online May 11, 2022
View: 6642   Download: 482  Web of Science: 40  Crossref: 41
Editorial
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Seonghwan Hwang, Won Kim
Clin Mol Hepatol. 2022;28(3):478-480.   Published online June 16, 2022
View: 2902   Download: 89
Original Article
1597
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding
Clin Mol Hepatol. 2021;27(2):329-345.   Published online January 20, 2021
View: 6621   Download: 221  Web of Science: 11  Crossref: 14
Review
Recent research trends and updates on nonalcoholic fatty liver disease
Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn
Clin Mol Hepatol. 2019;25(1):1-11.   Published online August 8, 2018
View: 18497   Download: 716  Web of Science: 69  Crossref: 66
Original Article
1388
Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis
Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki
Clin Mol Hepatol. 2018;24(1):61-76.   Published online November 20, 2017
View: 9181   Download: 170  Web of Science: 25  Crossref: 27
Case Report
Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy
Eun Hui Sim, Jung Hyun Kwon, Se Young Kim, Seung Min Jung, Lee-So Maeng, Jeong Won Jang, Kyu Won Chung
Clin Mol Hepatol. 2012;18(4):404-410.   Published online December 21, 2012
View: 7227   Download: 83  Crossref: 13
3
Validity and reliability of the nonalcoholic fatty Liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors
Kyung-Hun Lee, M.D., Sang Hoon Park, M.D., Yu Jin Kim, M.D., Kyung Rim Huh, M.D., Kwang Seon Min M.D., Sun-Young Jun M.D., Kyoung Oh Kim, M.D., Cheol Hee Park, M.D., Taeho Hahn, M.D., Kyo-Sang Yoo, M.D., Jong Hyeok Kim, M.D., Myung-Seok Lee, M.D., Choong Kee Park, M.D.
Clin Mol Hepatol. 2010;16(1):29-37.   Published online March 26, 2010
View: 5017   Download: 52  Crossref: 2
Current status of Liver diseases in Korea: nonalcoholic fatty Liver disease
Sang Hoon Park
Clin Mol Hepatol. 2009;15(60):34-39.   Published online December 31, 2009
View: 7089   Download: 45  Crossref: 19
2
Pathology of nonalcoholic steatohepatitis
Yoon Mi Jeen , So Young Jin
Clin Mol Hepatol. 2009;15(2):122-130.   Published online June 30, 2009
View: 4980   Download: 56  Crossref: 3
5
Nonalcoholic Steatohepatitis
So-Young Jin
Clin Mol Hepatol. 2006;12(3):455-459.   Published online January 1, 2000
View: 2537   Download: 20
3
Antioxidant Status in Nonalcoholic Steatohepatitis
Kyung Sik Park, M.D., Byoung Kuk Jang, M.D., Ki Min Kwon, M.D., Woo Jin Chung, M.D., Kwang Bum Cho, M.D., Jae Seok Hwang, M.D., Sung Hoon Ahn, M.D., Kyo Cheol Mun, M.D. and Young Hwan Kim, M.D.
Clin Mol Hepatol. 2005;11(2):135-143.   Published online January 1, 2000
View: 2562   Download: 26
Relationship between the Severity of Liver Damage and the Serum Leptin Level for Nonalcoholic Fatty Liver Disease
Kyoung Oh Kim, M.D., Sang Hoon Park, M.D., Cheol Hee Park, M.D., Tai Ho Han, M.D., Kyo-Sang Yoo, M.D., Jong Hyeok Kim, M.D., Myung Seok Lee, M.D., Dong Jun Kim, M.D., Choong Kee Park, and Hyun-Deuk Cho, M.D.
Clin Mol Hepatol. 2005;11(1):51-58.   Published online January 1, 1970
View: 2510   Download: 36
The Prevalence of Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease
Ki Won Moon, M.D., Joung Muk Leem, M.D., Sang Seok Bae, M.D., Ki Man Lee, M.D., Seok Hyung Kim, M.D.*, Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.
Clin Mol Hepatol. 2004;10(3):197-206.   Published online January 1, 1970
View: 3080   Download: 58
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 801
TOTAL : 1773576
Close layer